LTRN
Lantern Pharma Inc
NASDAQ: LTRN · HEALTHCARE · BIOTECHNOLOGY
$2.05
+3.54% today
Updated 2026-04-30
Market cap
$27.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$1 – $6
Volume
0.7M
Lantern Pharma Inc (LTRN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-123.50%
ROA
-61.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-1.73M | — | — | — |
| 2019 | $0.00 | $-2.43M | — | — | — |
| 2020 | $0.00 | $-5.91M | — | — | — |
| 2021 | $0.00 | $-12.36M | — | — | — |
| 2022 | $0.00 | $-14.26M | — | — | — |
| 2023 | $0.00 | $-15.96M | — | — | — |
| 2024 | $0.00 | $-20.78M | — | — | — |
| 2025 | $0.00 | $-17.12M | — | — | — |